264 related articles for article (PubMed ID: 31226638)
1. Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy.
Liu D; Chen L; Zhao H; Vaziri ND; Ma SC; Zhao YY
Biomed Pharmacother; 2019 Sep; 117():108990. PubMed ID: 31226638
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
Dzobo K; Thomford NE; Senthebane DA
OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
[TBL] [Abstract][Full Text] [Related]
3. Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling.
Hwang SY; Deng X; Byun S; Lee C; Lee SJ; Suh H; Zhang J; Kang Q; Zhang T; Westover KD; Mandinova A; Lee SW
Cell Rep; 2016 Jun; 16(1):28-36. PubMed ID: 27320923
[TBL] [Abstract][Full Text] [Related]
4. Advances in targeting the WNT/β-catenin signaling pathway in cancer.
Chatterjee A; Paul S; Bisht B; Bhattacharya S; Sivasubramaniam S; Paul MK
Drug Discov Today; 2022 Jan; 27(1):82-101. PubMed ID: 34252612
[TBL] [Abstract][Full Text] [Related]
5. Small Molecules Inspired by the Natural Product Withanolides as Potent Inhibitors of Wnt Signaling.
Sheremet M; Kapoor S; Schröder P; Kumar K; Ziegler S; Waldmann H
Chembiochem; 2017 Sep; 18(18):1797-1806. PubMed ID: 28678390
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges.
Serafino A; Giovannini D; Rossi S; Cozzolino M
Expert Opin Drug Discov; 2020 Jul; 15(7):803-822. PubMed ID: 32281421
[TBL] [Abstract][Full Text] [Related]
7. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
Yan M; Li G; An J
Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
[TBL] [Abstract][Full Text] [Related]
8. Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.
Liu Z; Wang P; Wold EA; Song Q; Zhao C; Wang C; Zhou J
J Med Chem; 2021 Apr; 64(8):4257-4288. PubMed ID: 33822624
[TBL] [Abstract][Full Text] [Related]
9. Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy.
Tewari D; Bawari S; Sharma S; DeLiberto LK; Bishayee A
Pharmacol Ther; 2021 Nov; 227():107876. PubMed ID: 33930452
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.
Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J
Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983
[TBL] [Abstract][Full Text] [Related]
11. Screening for natural products that affect Wnt signaling activity.
Ishibashi M
J Nat Med; 2019 Sep; 73(4):697-705. PubMed ID: 31147959
[TBL] [Abstract][Full Text] [Related]
12. Effects of natural compounds on Xenopus embryogenesis: a potential read out for functional drug discovery targeting Wnt/β-catenin signaling.
Amado NG; Fonseca BF; Cerqueira DM; Reis AH; Simas AB; Kuster RM; Mendes FA; Abreu JG
Curr Top Med Chem; 2012; 12(19):2103-13. PubMed ID: 23167799
[TBL] [Abstract][Full Text] [Related]
13. The recent update and advancements of natural products in targeting the Wnt/β-Catenin pathway for cancer prevention and therapeutics.
Saikia L; Gogoi B; Sen S; Tonk RK; Kumar D; Dutta PP
Med Oncol; 2024 May; 41(7):164. PubMed ID: 38816663
[TBL] [Abstract][Full Text] [Related]
14. Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities.
Huang P; Yan R; Zhang X; Wang L; Ke X; Qu Y
Pharmacol Ther; 2019 Apr; 196():79-90. PubMed ID: 30468742
[TBL] [Abstract][Full Text] [Related]
15. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases.
Serafino A; Sferrazza G; Colini Baldeschi A; Nicotera G; Andreola F; Pittaluga E; Pierimarchi P
Expert Opin Drug Discov; 2017 Feb; 12(2):169-186. PubMed ID: 27960558
[TBL] [Abstract][Full Text] [Related]
16. The potential of targeting Wnt/β-catenin in colon cancer.
Sebio A; Kahn M; Lenz HJ
Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
[TBL] [Abstract][Full Text] [Related]
17. New insights into the role and mechanism of Wnt/β-catenin signalling in kidney fibrosis.
Zuo Y; Liu Y
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():38-43. PubMed ID: 30298654
[TBL] [Abstract][Full Text] [Related]
18. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.
Kulak O; Chen H; Holohan B; Wu X; He H; Borek D; Otwinowski Z; Yamaguchi K; Garofalo LA; Ma Z; Wright W; Chen C; Shay JW; Zhang X; Lum L
Mol Cell Biol; 2015 Jul; 35(14):2425-35. PubMed ID: 25939383
[TBL] [Abstract][Full Text] [Related]
19. A zebrafish chemical suppressor screening identifies small molecule inhibitors of the Wnt/β-catenin pathway.
Nishiya N; Oku Y; Kumagai Y; Sato Y; Yamaguchi E; Sasaki A; Shoji M; Ohnishi Y; Okamoto H; Uehara Y
Chem Biol; 2014 Apr; 21(4):530-540. PubMed ID: 24684907
[TBL] [Abstract][Full Text] [Related]
20. [Screening for Chemical Suppressors of the Wnt/β-catenin Signaling Pathway].
Nishiya N
Yakugaku Zasshi; 2017; 137(2):133-136. PubMed ID: 28154320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
